Suzanne St.rose

Suzanne St.Rose, DVM, PhD, EMBA, is an experienced leader in the field of epidemiology and real-world evidence, currently serving as Head of RWE CREA at Boehringer Ingelheim since December 2020, where strategic and scientific guidance for CNS and Retinal Health therapeutic areas is provided. Previous roles include Director of Epidemiology at AbbVie and Allergan, along with positions in Pharmacoepidemiology at Takeda Pharmaceuticals in Europe and Canada. Early career experiences include work as a Regional Epidemiologist at GSK Vaccines and statistical positions at The Royal Marsden NHS Foundation Trust and the London School of Hygiene & Tropical Medicine. Educational qualifications include an Executive MBA from the University of Warwick, a PhD in Epidemiology from The University of Edinburgh, and a DVM degree from the University of the West Indies.